Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/1995
08/10/1995DE4403789A1 Mittel zur visuellen Markierung von Körpergewebe Means for visually marking body tissue
08/10/1995CA2182686A1 Agent for marking bodily tissues
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/09/1995EP0665756A1 Process and device for producing liquid, dispersed systems
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/08/1995US5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use
08/08/1995US5439828 Fluorgenic and chomogenic three-dimensional ionophores as selective reagents for detecting ions in biological fluids
08/08/1995US5439799 Agent and process for treating body fluids in the determination of neopterin
08/08/1995US5439686 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
08/08/1995US5439669 Biological imaging emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
08/08/1995US5439668 Heterocyclic chelating agents
08/08/1995US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production
08/03/1995WO1995020666A2 Transgenic non-human mammals with progressive neurologic disease
08/03/1995WO1995020597A1 Modified oligonucleotides
08/03/1995WO1995020580A1 Macrocyclic octaaza compounds
08/03/1995WO1995020405A1 Oral magnetic particle formulation
08/03/1995WO1995020353A1 Functionalized aza-bimacrocyclic ligands for imaging applications
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995DE4403039A1 Oktaazamakrocyclen, deren Metallkomplexe, Verfahren zu deren Herstellung, diese Komplexe enthaltende Mittel sowie deren Verwendung in Diagnostik und Therapie Oktaazamakrocyclen, their metal complexes, to processes for their preparation, agents containing these complexes and their use in diagnostics and therapy
08/03/1995CA2182311A1 Transgenic non-human mammals with progressive neurologic disease
08/03/1995CA2182213A1 Oral magnetic particle formulation
08/03/1995CA2180727A1 Modified oligonucleotides
08/02/1995EP0664819A1 Chelating polymers.
08/02/1995EP0664714A1 Mr imaging compositions, based on poly(alkyleneoxide)
08/02/1995EP0664713A1 Therapeutic and diagnostic imaging compositions and methods
08/02/1995EP0517788B1 19 f labelled compounds as nmr imaging and spectroscopy agents
08/02/1995EP0474833B1 Stable microbubbles suspensions injectable into living organisms
08/01/1995US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
08/01/1995CA1336497C Immunoconjugates for cancer diagnosis and therapy
08/01/1995CA1336494C Emulsions of highly fluorinated organic compounds
07/1995
07/27/1995WO1995017910A3 Paramagnetic diagnostic formulations and their method of use
07/27/1995WO1995017448A3 Cascade polymers with iodine aromatic compounds
07/27/1995WO1995009848A3 Polyazacycloalkanes as dichelants
07/26/1995EP0663840A1 Preparation of further diagnostic agents
07/26/1995EP0663829A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use
07/25/1995US5435991 Use of persistent heterocyclic free-radicals in magnetic resonance imaging
07/20/1995WO1995019347A1 Functionalized macrocyclic ligands for imaging applications
07/20/1995WO1995019199A1 A container for diagnostic contrast compositions
07/20/1995WO1995019186A2 Contrast media for x-ray and magnetic resonance imaging
07/20/1995WO1995019185A1 Functionalized aza-macrobicyclic ligands for imaging applications
07/20/1995WO1995019184A1 Polymeric microparticles containing agents for imaging
07/20/1995WO1995015335A3 Pretargeting methods and compounds
07/20/1995CA2181341A1 A container for diagnostic contrast compositions
07/19/1995EP0662972A1 3-,8-substituted deuteroporphyrine derivatives, pharmaceuticals containing them and methods of producing them
07/18/1995US5434050 Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
07/18/1995US5433207 Method and apparatus to characterize ultrasonically reflective contrast agents
07/13/1995WO1995018832A1 New polyaminocarboxylate chelators
07/13/1995DE4400640A1 Diagnosis and treatment of malignant tumours
07/13/1995CA2180662A1 New polyaminocarboxylate chelators
07/12/1995EP0662005A1 Microparticle preparations made from biodegradable copolymers
07/12/1995EP0662004A1 Use of persistent free-radicals in magnetic resonance imaging
07/12/1995EP0662001A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents
07/12/1995EP0481087B1 Molded body of water-absorbing resin, process for producing molded body, use thereof, and process for preparing water-absorbing resin
07/11/1995US5432171 Water soluble texaphyrin metal complexes for viral deactivation
07/11/1995US5431901 Selective isotopic labeling of spin labels for electron spin resonance spectroscopy
07/11/1995CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
07/06/1995WO1995018156A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
07/06/1995WO1995017910A2 Paramagnetic diagnostic formulations and their method of use
07/06/1995WO1995014491A3 Metal-ion chelates with acidic saccharides and glycosaminoglycans
07/05/1995EP0661279A1 Polyaminated ligands, metal complexes, process for their preparation and diagnostic and therapeutic applications
07/05/1995EP0660936A1 Up-converting reporters for biological and other assays using laser excitation techniques
07/05/1995EP0660925A1 Alkoxyamide derivatized chelates for mri
07/05/1995EP0660724A1 Improvements in or relating to contrast agents
07/05/1995EP0660714A1 Novel liposomal drug delivery systems
07/05/1995EP0660687A1 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes
07/04/1995US5430051 Photodynamic diagnosis and therapy of rheumatic diseases
07/04/1995US5429824 Compound for diagnostic imaging a 4-(1,1,3,3-tetramethylbutyl) phenol polymer of ethylene oxide and formaldehyde
07/04/1995US5429814 Molecular sieve-enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract
07/04/1995CA1336165C Method for introducing oxygen-17 into tissues for imaging in a magnetic resonance imaging system
07/04/1995CA1336164C Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agent
07/04/1995CA1336162C Method for myocardial infarct risk assessment
06/1995
06/29/1995WO1995017673A1 Ocular diagnostics and therapies
06/29/1995WO1995017451A1 Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents
06/29/1995WO1995017448A2 Cascade polymers with iodine aromatic compounds
06/29/1995WO1995017380A1 Tetraiodopyrrole derivatives as contrast medium and as antiseptic
06/29/1995WO1995017125A1 Inhalable contrast agent
06/29/1995CA2179624A1 Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents
06/29/1995CA2179617A1 Inhalable contrast agent
06/28/1995EP0659764A2 Peptides modified by the phosphine group for marking with 99mTC and 186-188Re or paramagnetic agents
06/28/1995EP0659056A1 Artifact-free imaging contrast agent
06/28/1995EP0460171B1 Cd3 specific recombinant antibody
06/27/1995US5428155 PH controlled sulfomethylation of 1,4,7,10-tetraazacyclododecane; displacement with sodium cyanide; hydrolysis to symmetrical acetic acid side groups
06/27/1995US5428154 Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions
06/27/1995US5428013 Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
06/27/1995US5427925 Recombniant method for making leukemia inhibitor factor
06/27/1995US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging
06/27/1995US5427099 Marker for magnetic resonance imaging
06/22/1995WO1995016468A1 Xenogeneic tissue implant in ear pinna
06/22/1995WO1995016467A1 Gas mixtures useful as ultrasound contrast media
06/22/1995WO1995014492A3 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
06/22/1995WO1995007992A3 Cloned glutamic acid decarboxylase
06/21/1995EP0658121A1 Film-forming x-ray contrast compositions
06/21/1995EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream
06/21/1995EP0504340B1 Method for the preparation of stable suspensions of hollow gas-filled microspheres suitable for ultrasonic echography
06/21/1995CN1028963C Concentrated stabilized microbubble-type ultrasonic imaging agent
06/20/1995US5425366 Ultrasonic contrast agents for color Doppler imaging
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015978A1 Pretargeting methods and compounds
06/15/1995WO1995015769A1 Preparation and use of immunoconjugates
06/15/1995CA2178477A1 Pretargeting methods and compounds